‹ All Posts
Kundan Motwani

5th Feb · SEBI-Registered Analyst

SAKAR HEALTHCARE:

Q3 SL NET PROFIT 102M RUPEES VS 45M (YOY) SAKAR HEALTHCARE: Q3 EBITDA 186M RUPEES VS 118M (YOY) || Q3 EBITDA MARGIN 26.4% VS 27.1% (YOY)

SAKAR

#WatchOutFor#StockInNews
887 likes·46 comments